(Q46882457)

26 December 2017

title

Renal effects of human urotensin-II in rats with experimental congestive heart failure (English)

1 reference

26 December 2017

main subject

congestive heart failure

1 reference

Elena Ovcharenko

1

1 reference

26 December 2017

Zaid Abassi

2

1 reference

26 December 2017

Irith Rubinstein

3

1 reference

26 December 2017

Aviva Kaballa

4

1 reference

26 December 2017

Aaron Hoffman

5

1 reference

26 December 2017

Joseph Winaver

6

1 reference

26 December 2017

language of work or name

English

0 references

publication date

5 January 2006

1 reference

26 December 2017

Nephrology Dialysis Transplantation

published in

1 reference

26 December 2017

volume

21

1 reference

26 December 2017

issue

5

1 reference

26 December 2017

page(s)

1205-1211

1 reference

26 December 2017

Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK049

Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK049

Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK049

Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK049

Plasma urotensin in human systolic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK049

Congestive heart failure and expression of myocardial urotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK049

Renal and circulatory mechanisms in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK049

Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK049

Depressor and regionally-selective vasodilator effects of human and rat urotensin II in conscious rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK049

Complex effects of Gillichthys urotensin II on rat aortic strips

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK049

Urotensin II is a nitric oxide-dependent vasodilator and natriuretic peptide in the rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK049

Bolus injection of human UII in conscious rats evokes a biphasic haemodynamic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK049

Pharmacology of the urotensin-II receptor antagonist palosuran (ACT-058362; 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea sulfate salt): first demonstration of a pathophysiological role of the urotensin System

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFK049

21 January 2018

Identifiers

DOI

10.1093/NDT/GFK049

1 reference

26 December 2017

1 reference

26 December 2017